Clinical Research

One Way To Fix Medicine- Publish Missing Trial Data

Should researchers be obligated to publish null results?  Should they have to publish all trial data? Missing data  distorts the scientific record, so that clinical decisions cannot be based on the best evidence, and that can harm patients and lead to futi ...

Article - News Staff - Jan 22 2012 - 8:00pm

Scars No More: Hearts Regrow After Treatment With Patents' Own Cells

A Cedars-Sinai Heart Institute clinical trial showed that treating heart attack patients with an infusion of their own heart-derived cells helps damaged hearts re-grow healthy muscle.  Patients who underwent the stem cell procedure demonstrated a significa ...

Article - News Staff - Feb 13 2012 - 9:43pm

ENT Devices Market Outlook & Forecasts For Europe & South America

ReportsnReports adds to its store new market research reports on "ENT Devices Market Outlook to 2018- Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others" for following geographies / countries: Europe, South&Central America, ...

Article - Newswire - Apr 22 2012 - 2:30am

New Strategies For The United States Clinical Laboratory Market

Clinical laboratory testing includes diagnostic testing that occurs in hospital, private reference, and physician office laboratories. This briefing will provide an overview of industry trends as well as the competitive strategies currently utilized by re ...

Article - Newswire - Apr 19 2012 - 3:00pm

ClinicalTrials.gov Registered Trials Weak When It Comes To Size And Methodology

Clinical studies, the central means by which preventive, diagnostic, and therapeutic strategies are evaluated,  that were registered between 2007-2010 were dominated by small, single-center trials and contained significant heterogeneity (different in natur ...

Article - News Staff - May 4 2012 - 4:30am

WATCHMAN® Device Shows 75 Percent Reduction In Stroke Risk In Patients With Atrial Fibrillation

Results Presented at Heart Rhythm Society from ASA Plavix Study Evaluating Boston Scientific Left Atrial Appendage Closure Device  Boston Scientific Corporation announces results from the ASA Plavix (ASAP) Study, which studied the WATCHMAN(R) Left Atrial ...

Article - Newswire - Aug 6 2012 - 2:49pm

EVOLVE Trial Clinical Results Confirm Data Of The Boston Scientific SYNERGY™ Stent

Follow-up Data from EVOLVE Trial Presented at EuroPCR; Trial is Evaluating Next-Generation Everolimus-Eluting Platinum Chromium Coronary Stent with Ultra-Thin Bioabsorbable Abluminal Polymer  ...

Article - Newswire - May 15 2012 - 8:00pm

High Uptake In The U.S. Tissue Engineering Market

Increased literature on tissue engineering will accelerate the products' adoption among physicians and patients. Tissue engineering has the ability to hasten the treatment of wounds and other conditions. This procedure's rising popularity as an ...

Article - Newswire - May 18 2012 - 1:30am

Convergent Procedure Ablation May Restore Persistent Atrial Fibrillation Patients To Normal Sinus Rhythm

nContact, Inc., a provider of epicardial ablation devices, announced that new long-term physician data demonstrated promising clinical outcomes for the multidisciplinary Convergent Procedure in the treatment of persistent atrial fibrillation (AF), with ov ...

Article - Newswire - May 17 2012 - 3:30pm

Biomarkers Map Path To New Blood Test For Bowel Cancer

A team of Australian scientists has identified new genes that show identifiable changes in the blood of people with bowel cancer. The discovery has the potential to underpin a new cost-effective blood test that would signal the early stages of bowel cance ...

Article - News Staff - May 20 2012 - 4:13pm